🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Leukemia cells grow and divide fast and out of control. In normal cells, ce...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2018-04-20
Trial ID
NCT03515200
Randomized phase III trial to compare the effectiveness of different chemot...
Status
Completed
Location
Children's Oncology Group
Start Date
1996-08
Trial ID
NCT00002798
An experimental drug called EZN-3042 targets survivin, a protein expressed ...
Status
Terminated
Location
Childrens Hospital Los Angeles
Start Date
2010-08-24
Trial ID
NCT01186328
Treatments Being Tested
This is a Phase II clinical trial testing the use of two antigen-directed t...
Status
Recruiting
Location
Novant Health Presbyterian Hemby Children's Hospital
Start Date
2025-01-23
Trial ID
NCT06533748
The goal of this study is to find a safe dose of sirolimus that can be used...
Status
Withdrawn
Location
Children's Healthcare of Atlanta
Start Date
2009-06
Trial ID
NCT00957320
Treatments Being Tested
The goal of this study is to provide sufficient therapy during the time a p...
Status
Recruiting
Location
Rady Children's Hospital
Start Date
2024-12-26
Trial ID
NCT06289673
The purpose of Phase 1b of this study is to: * Asses the safety, tolerabil...
Status
Completed
Location
University of California San Francisco Benioff Childrens Hospital Oakland
Start Date
2015-02-16
Trial ID
NCT02303821
This is a clinical trial testing whether the addition of one of two chemoth...
Status
Recruiting
Location
Rady Children's Hospital
Start Date
2024-12-27
Trial ID
NCT06390319
Phase II trial to study the effectiveness of 506U78 in treating patients wi...
Status
Completed
Location
Children's Oncology Group
Start Date
1997-06
Trial ID
NCT00002970
Treatments Being Tested
Quizartinib is an experimental drug. It is not approved for regular use. It...
Status
Active Not Recruiting
Location
Loma Linda University Cancer Center
Start Date
2018-08-15
Trial ID
NCT03793478
Treatments Being Tested